Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-04
2011-01-04
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S266400, C544S287000, C544S293000
Reexamination Certificate
active
07863283
ABSTRACT:
The present invention relates to sulphoximine-substituted quinazoline derivatives of the formula (I), processes for their preparation and their use as a medicament for the treatment of various diseases.
REFERENCES:
patent: 9813354 (1998-04-01), None
patent: 0121595 (2001-03-01), None
patent: 2006099974 (2006-09-01), None
patent: PCTEP2008005045 (2008-09-01), None
Hennequin, Laurent F., et al. “Design and Structure-Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors.” Journal of Medicinal Chemistry (1999): vol 42, No. 26.
Haerter Michael
Mengel Anne
Nguyen Duy
Schaefer Martina
Schirok Hartmut
Bayer Schering Pharma AG
McDowell Brian
Millen White Zelano & Branigan P.C.
Wilson James O
LandOfFree
Sulphoximine-substituted quinazoline derivatives as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulphoximine-substituted quinazoline derivatives as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulphoximine-substituted quinazoline derivatives as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2722620